NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation
Background. Bone marrow-derived mesenchymal stem cells (BMSCs) have blossomed into an effective approach with great potential for the treatment of liver fibrosis. The aim of this study was to investigate the underlying antifibrosis mechanisms by which the BMSC inhibit activated hepatic stellate cell...
Saved in:
Main Authors: | Haowen Qiao (Author), Yu Zhou (Author), Xingping Qin (Author), Jing Cheng (Author), Yun He (Author), Yugang Jiang (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NADPH Oxidases: Redox Regulators of Stem Cell Fate and Function
by: Tullia Maraldi, et al.
Published: (2021) -
Inhibition of NADPH Oxidases Prevents the Development of Osteoarthritis
by: Jin Han, et al.
Published: (2022) -
Resveratrol Inhibits Hepatic Stellate Cell Activation via the Hippo Pathway
by: Chunxue Li, et al.
Published: (2021) -
Conditioned Medium from Human Amnion-Derived Mesenchymal Stem Cells Regulates Activation of Primary Hepatic Stellate Cells
by: Qingjie Fu, et al.
Published: (2018) -
Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
by: Shiyun Pu, et al.
Published: (2021)